Ornithine decarboxylase, polyamines and CD11b expression in HL-60 cells during differentiation induced by retinoic acid.
Polyamines (PA) and retinoic acid affect mammalian cell growth, differentiation and apoptosis. Retinoic acid induces granulocytic differentiation of mieloid cell lines and, during this process, is responsible for the expression of CD11b, a surface antigen. In this study we investigate the effects of retinoic acid on HL-60 cells, monitoring ornithine decarboxylase (ODC) activity (enzyme rate of PA), putrescine (PUT), spermidine (SPD), spermine (SPM) levels, CD11b myeloid surface marker differentiation, cell cycle, and apoptosis. ODC activity and PUT levels are correlated with mieloid cell differentiation induced by retinoic acid treatment. Only the ODC/PUT ratio is connected with retinoic acid treated HL-60 cells. Treated cultures show a decrease of proliferation and a cell block in the G0/G1 phase, with consequent diminished S phase. The G0/G1 and S phases are significantly related to ODC activity and to PUT and SPD behavior, whereas in differentiating condition only the decrease of PUT is related to the S phase. CD11b expression, stimulated by retinoic acid treatment, is associated with the SPM trend. Total PA behavior agrees with apoptotic cell increase after 96 h of stimulation. Our data show that retinoic acid treatment modifies ODC activity and the turnover of PA. PUT, SPD and SPM, therefore, have a different role, and may be involved in the differentiative/apoptotic program of retinoic acid treated HL-60 cells.
Human Morphology Department, LITA of Segrate, State University of Milan, Via Mangiagalli 31, 20133, Italy. giordano.stabellini@unimi.it
Giordano
G
Stabellini
F
F
Brugnoli
C
C
Calastrini
L
L
Vizzotto
M
M
Vertemati
T
T
Baroni
E
E
Caramelli
L
L
Marinucci
A
A
Pellati
V
V
Bertagnolo
D017209:Apoptosis / Q000187:drug effects; D039481:CD11b Antigen / Q000096:biosynthesis*; D002454:Cell Differentiation / Q000187:drug effects; D049109:Cell Proliferation / Q000187:drug effects; D018922:HL-60 Cells; D006801:Humans; D009955:Ornithine Decarboxylase / Q000096:biosynthesis*; D011073:Polyamines / Q000819:agonists* / Q000378:metabolism; D014212:Tretinoin / Q000494:pharmacology*
D039481:CD11b Antigen; D011073:Polyamines; D014212:Tretinoin; D009955:Ornithine Decarboxylase